Nykode Therapeutics ASA banner
N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 3.084 NOK 3.14% Market Closed
Market Cap: kr1B

Wall Street
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 4.59 NOK with a low forecast of 4.545 NOK and a high forecast of 4.725 NOK.

Lowest
Price Target
4.545 NOK
47% Upside
Average
Price Target
4.59 NOK
49% Upside
Highest
Price Target
4.725 NOK
53% Upside
Nykode Therapeutics ASA Competitors:
Price Targets
SUPN
Supernus Pharmaceuticals Inc
30% Upside
RYI
Ryerson Holding Corp
50% Upside
SDGR
Schrodinger Inc
113% Upside
LAND
Gladstone Land Corp
19% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NYKD's stock price target?
Price Target
4.59 NOK

According to Wall Street analysts, the average 1-year price target for NYKD is 4.59 NOK with a low forecast of 4.545 NOK and a high forecast of 4.725 NOK.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett